US Patent Issued to Japan Tobacco on Aug. 26 for "Triazine compounds and pharmaceutical use thereof" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,398,111, issued on Aug. 26, was assigned to Japan Tobacco Inc. (Tokyo).

"Triazine compounds and pharmaceutical use thereof" was invented by Hironobu Nagamori (Osaka, Japan), Ikuo Mitani (Osaka, Japan), Masaki Yamashita (Osaka, Japan), Takahiro Hotta (Osaka, Japan), Yuichi Nakagawa (Osaka, Japan) and Masatoshi Ueda (Osaka, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a compound having an mPGES-1 inhibitory activity and useful for the prophylaxis or treatment of pain, rheumatism, osteoarthritis, fever, Alzheimer's disease, multiple sclerosis, arteriosclerosis, glaucoma, ocular hypertension, ischemic retinal disease, systemic scleroderm...